Phase 4Completed
Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHD (IDEAL)
Atorvastatin Compared With Simvastatin In The Prevention of CHD Morbidity And Mortality In Patients With CHD
- Sponsor
- Pfizer (Industry)
- Enrollment
- 8,600 planned
- Conditions
- Cardiovascular Diseases
- Interventions
- atorvastatin; simvastatin
- Ages
- children, adults, older adults
- Registry
- NCT00159835
Full record on ClinicalTrials.gov
From the registry
To investigate whether a long-term strategy to lower LDL cholesterol with atorvastatin as much as possible will improve prognosis in CHD patients compared with a strategy reflecting current best clinical practice with simvastatin.
Primary outcomes
- Time to of a major coronary event: 1) non-fatal acute myocardial infarction 2) coronary death 3) resuscitated cardiac arrest
History
Last registry update
Registered
Study completion
Started